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Introduction Atlanto-occipital fusion (AOF), also known as “occipitalization of the atlas” or “atlas assimilation”, is one of the caniovertebral
junction (CVJ) disease characterized with fusion of the atlas and the base of the occipital bone. Due to its rare incidence, asymptomatic onset and
the limited techniques available, there are very few studies on AOF.
Although sequencing technique has been successfully applied in studying small sample size of many CVJ diseases, for instance, a homozygous
mutation on gene MEOX1 was detected and proved to be one of the pathological mutations for type II Klippel-Feil syndrome using the whole-
exome sequencing (WES) technique, there is not such a study on AOF so far.
Aim and methods In this study, we performed WES and SNP (Single-nucleotide Polymorphism) analysis on clinical samples from a Chinese Han
family with AOF son to understand the genomic basis of AOF. This study has the ethics approval (No.2014S010) from the Beijing Institute of
Genomics, Chinese Academy of Sciences. The clinical investigations were informed to all participants and written informed consents were
received to allow the publication of this study. A total of 293 participants were selected for this study, including 220 healthy volunteers and 73 AOF
patients who have been diagnosed in the outpatient department of the China PLA General hospital, in which included a family samples of one
AOF patient and four healthy members. The peripheral blood samples were collected at the China PLA General hospital using standard
operational protocol. The hospital medical staff provided all medical reports. Furthermore, the exome sequencing data were stored at the internal
database of Beijing Institute of Genomics and it is available upon requests for research purposes only.
The peripheral bloods from all participants were collected for DNA isolation. Exome enrichment was conducted following the manufacturer’s
protocol with Illumina Hiseq2500 sequencing technique. Primers for PCR and qPCR amplifications of all target variants were designed using the
web-based Primer 3 software (http://biotools.umassmed.edu/bioapps/primer3). All variants were compared among family subjects, including the
proband, his parents and his two sisters. Genetic testing was then performed to inspect the candidate variant. The candidate variant was verified
by conservation of species and Gene Ontology Consortium (GO) cluster. CRISPR-Cas9 was then applied to edit CROCC for its verification.
Results
Conclusion A novel variant (chr1: c.4702C>T: p.R1568C) was identified for the first time on gene ciliary rootlet coiled-coil (CROCC) (MIM#
615776) based on comparison of the family WES sequencing data and analysis of experimental verifications of 220 healthy volunteers, 68
non-mutated and 5 mutated AOF patient samples. The SNP (chr1: c.4702C>T: p.R1568C) was found rare population frequency and could
change the protein CROCC structure that will reduce the expression of CROCC, and then directly affect the biological signaling transfer of
hedgehog pathway. Our results suggested that the candidate SNP (chr1: c.4702C>T: p.R1568C) could be one of the potential causes of the
development of AOF (or CVJ).



















changing from “C” to “T”
showed the amino acid
changed from arginine
to cysteine.
Figure 3. Location of the genes (IHH,
Smoothened, PTCH1, GLI1, GPC3, PTHrp)
in the hedgehog signaling pathway. This
pathway can be affected by the candidate
SNP mutation of CROCC and the genes
activation.
Figure 1. (A) The 
pedigree chart for 
the genotype of 









proband with a 
mutated “T” which 
was different from 
the rest of the 
family. (B) Sanger 
sequencing results 
for the candidate 
variant in sporadic 
patients.
Figure 4. The real-time PCR results for CROCC, IHH, PTCH1, GLI1, GPC3, PTHrp. The
red column was the gene expression for the patients with candidate SNP, the gray
column for the health donors’ gene expression, and the blue column for the patients
without candidate SNP. Each bar in this chart is the average cq values of real-time PCR.
The gene expression level (CROCC and downstream genes including GLI1, GPC3,
PTHrp) of AOF patients with candidate SNP (red bar) were reduced compared with those
of healthy samples (blue bar).
Figure 5. CRISPR-Cas9 and
immunofluorescence results for
CROCC knock-down cells. (A) Cell
transformation. (B) qPCR for
transformed monoclonal cells. (C)
Sanger sequencing results
showed that target sequence was
knocked down in the testing cell
line. (D) immunofluorescence for
the control cell 293T and RPE, and
the testing cell line of 293T
knocked down cells. (E)
immunofluorescence for cilia in the
control and the testing cell line.
